BXC vs STE · rev $2.95B vs P/E 25, rev $5.46B
BlueLinx Holdings Inc (BXC) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
BlueLinx Holdings Inc (BXC) is a industrial distribution company listed on NYSE.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported BXC revenue for 2024-12-28 was $2.95B. Net income was $53.1M. Revenue was down 5.9% from 2023-12-30 to 2024-12-28. BXC currently screens at market cap $423.4M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
BXC currently screens at market cap $423.4M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the BXC and STE stock pages for the full models.
Not investment advice.